Gentler approach to tough myeloma: lower doses may help frail patients

This study tests a combination of three drugs (isatuximab, pomalidomide, and dexamethasone) at lower-than-standard doses in people with multiple myeloma that has returned or not responded to treatment. The goal is to see if this gentler approach is safe and effective for patients who are especially vulnerable to drug side effects due to age or other health problems. About 6 participants will receive the treatment, and researchers will measure how many achieve at least a partial response.